Search

Objective: To analyze the rates of complications after pediatric temporal bone fractures (TBF) and the utility of the longitudinal, transverse, and mixed versus the otic capsule sparing (OCS) and otic capsule violating (OCV) classification systems in predicting these complications. Data Sources: PubMed, Scopus, and CINAHL. Review Methods: Per PRISMA guidelines, studies of children with TBFs were included. Meta‐analyses of proportions were performed. Results: A total of 22 studies with 1376 TBFs were included. Children with TBF had higher rates of conductive hearing loss (CHL) than sensorineural hearing loss (SNHL) (31.3% [95% confidence interval [CI] 23.2‐40.1] vs 12.9% [95% CI 8.9‐17.5]). No differences in both CHL and SNHL were seen between longitudinal and transverse TBFs; however, OCV TBFs had higher rates of SNHL than OCS TBFs (59.3% [95% CI 27.8‐87.0] vs 4.9% [95% CI 1.5‐10.1]). Of all patients, 9.9% [95% CI 7.2‐13.1] experienced facial nerve (FN) paresis/paralysis, and 13.4% [95% CI 5.9‐23.2] experienced cerebrospinal fluid otorrhea. Transverse TBFs had higher rates of FN paresis/paralysis than longitudinal (27.7% [95% CI 17.4‐40.0] vs 8.6% [95% CI 5.2‐12.8]), but rates were similar between OCS and OCV TBFs. Conclusion: CHL was the most common complication after TBF in children; however, neither classification system was superior in identifying CHL. The traditional system was more effective at identifying FN injuries, and the new system was more robust at identifying SNHL. While these results suggest that both classification systems might have utility in evaluating pediatric TBFs, these analyses were limited by sample size. Future research on outcomes of pediatric TBFs stratified by type of fracture, mainly focusing on long‐term outcomes, is needed. [ABSTRACT FROM AUTHOR]

Objective: To review the literature on pneumococcal vaccination compliance rates among cochlear implant (CI) patients and to examine the utility of intervention programs on increasing vaccination rates. Data Sources: PubMed, Scopus, and CINAHL. Review Methods: A systematic review was performed following PRISMA guidelines. Studies of pneumococcal vaccination rates at baseline and before and after the implementation of a quality improvement (QI) intervention were included. A total of 641 studies were screened, and 13 studies met inclusion criteria. Meta‐analyses of pneumococcal vaccination rates pre‐ and post‐QI intervention in CI patients were performed. Results: A total of 12,973 children and adults were included. The baseline PCV13 and PPSV23 vaccination rates were 53.45% (95% CI, 37.02%‐69.51%) and 42.53% (95% CI, 31.94%‐53.48%), respectively. Comparing children and adults, PCV13 and PPSV23 baseline vaccination rates were not statistically significant. The PPSV23 vaccine rate after QI initiatives was significantly higher than the baseline rate at 83.52% (95% CI, 57.36%‐98.46%). After these interventions, patients had a 15.71 (95% CI, 4.32‐57.20, P <.001) increased odds of receiving PPSV23 vaccination compared to before QI implementation. Conclusions: The baseline rates of PCV13 and PPSV23 are highly variable and lower than expected, given current vaccination recommendations for CI patients. QI programs appear successful in increasing compliance rates with the PPSV23 vaccination; however, they are still far from full compliance. Further intervention programs with stricter surveillance, monitoring, and follow‐up systems are needed to achieve improved compliance with the PCV13 and PPSV23 vaccination in CI recipients. [ABSTRACT FROM AUTHOR]